{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:40:48Z","timestamp":1790505648133,"version":"4.1.0"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T00:00:00Z","timestamp":1537315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11910-018-0889-4","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T09:10:42Z","timestamp":1537348242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Imaging the Autonomic Nervous System in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Karoline","family":"Knudsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Borghammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,19]]},"reference":[{"issue":"1","key":"889_CR1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00441-018-2851-9","volume":"373","author":"S Orimo","year":"2018","unstructured":"\u2022\u2022 Orimo S, Ghebremedhin E, Gelpi E. Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD? Cell Tissue Res. 2018;373(1):267\u201386 Excellent recent review on the degree of autonomic nervous system damage in PD.","journal-title":"Cell Tissue Res"},{"key":"889_CR2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.57.3.456","volume":"57","author":"RD Abbott","year":"2001","unstructured":"Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, et al. Frequency of bowel movements and the future risk of Parkinson\u2019s disease. Neurology. 2001;57:456\u201362.","journal-title":"Neurology"},{"key":"889_CR3","doi-asserted-by":"crossref","first-page":"e4.193","DOI":"10.1136\/jnnp-2015-312379.98","volume":"86","author":"KL Adams-Carr","year":"2015","unstructured":"Adams-Carr KL, Bestwick JP, Shribman S, Lees A, Schrag A, Noyce AJ. Constipation preceding Parkinson\u2019s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2015;86:e4.193\u2013e4.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"889_CR4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/jnnp-2015-311890","volume":"87","author":"AJ Noyce","year":"2016","unstructured":"Noyce AJ, Lees AJ, Schrag AE. The prediagnostic phase of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2016;87:871\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"889_CR5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White III CL, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010;119:689\u2013702.","journal-title":"Acta Neuropathol"},{"key":"889_CR6","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.25776","volume":"29","author":"E Gelpi","year":"2014","unstructured":"Gelpi E, Navarro-Otano J, Tolosa E, Gaig C, Compta Y, Rey MJ, et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord. 2014;29:1010\u20138.","journal-title":"Mov Disord"},{"key":"889_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, et al. Accumulation of alpha-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol. 2014;127:235\u201341.","journal-title":"Acta Neuropathol"},{"key":"889_CR8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases. Mov Disord. 2012;27:716\u20139.","journal-title":"Mov Disord"},{"key":"889_CR9","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P. Pathological alpha-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol. 2016;79:940\u20139.","journal-title":"Ann Neurol"},{"key":"889_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-015-1485-1","volume":"131","author":"T Uchihara","year":"2016","unstructured":"Uchihara T, Giasson BI. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. 2016;131:49\u201373.","journal-title":"Acta Neuropathol"},{"key":"889_CR11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna). 2003;110:517\u201336.","journal-title":"J Neural Transm (Vienna)"},{"key":"889_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-1838(98)00042-3","volume":"70","author":"AV Krassioukov","year":"1998","unstructured":"Krassioukov AV, Bygrave MA, Puckett WR, Bunge RP, Rogers KA. Human sympathetic preganglionic neurons and motoneurons retrogradely labelled with DiI. J Auton Nerv Syst. 1998;70:123\u20138.","journal-title":"J Auton Nerv Syst"},{"key":"889_CR13","first-page":"195","volume-title":"Gastroenterology","author":"WL Hasler","year":"2003","unstructured":"Hasler WL. Approach to the patient with gas and bloating. In: Yamada T, editor. Gastroenterology. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 195\u2013219."},{"key":"889_CR14","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1053\/j.gastro.2008.05.021","volume":"134","author":"ML Schubert","year":"2008","unstructured":"Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008;134:1842\u201360.","journal-title":"Gastroenterology"},{"key":"889_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40478-015-0236-9","volume":"3","author":"H Sumikura","year":"2015","unstructured":"Sumikura H, Takao M, Hatsuta H, Ito S, Nakano Y, Uchino A, et al. Distribution of alpha-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons. Acta Neuropathol Commun. 2015;3:57.","journal-title":"Acta Neuropathol Commun"},{"key":"889_CR16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00401-007-0193-x","volume":"113","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K. Parkinson\u2019s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol. 2007;113:421\u20139.","journal-title":"Acta Neuropathol"},{"key":"889_CR17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s004010050705","volume":"94","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Takahashi H. The intermediolateral nucleus and Clarke\u2019s column in Parkinson\u2019s disease. Acta Neuropathol. 1997;94:287\u20139.","journal-title":"Acta Neuropathol"},{"key":"889_CR18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-012-1028-y","volume":"124","author":"K Tredici Del","year":"2012","unstructured":"Del Tredici K, Braak H. Spinal cord lesions in sporadic Parkinson\u2019s disease. Acta Neuropathol. 2012;124:643\u201364.","journal-title":"Acta Neuropathol"},{"key":"889_CR19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease. Brain. 2008;131:642\u201350.","journal-title":"Brain"},{"key":"889_CR20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00687140","volume":"75","author":"F Gray","year":"1988","unstructured":"Gray F, Vincent D, Hauw JJ. Quantitative study of lateral horn cells in 15 cases of multiple system atrophy. Acta Neuropathol. 1988;75:513\u20138.","journal-title":"Acta Neuropathol"},{"key":"889_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870120203","volume":"12","author":"GK Wenning","year":"1997","unstructured":"Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12:133\u201347.","journal-title":"Mov Disord"},{"key":"889_CR22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00401-003-0811-1","volume":"107","author":"M Nishie","year":"2004","unstructured":"Nishie M, Mori F, Fujiwara H, Hasegawa M, Yoshimoto M, Iwatsubo T, et al. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Acta Neuropathol. 2004;107:292\u20138.","journal-title":"Acta Neuropathol"},{"key":"889_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00401-005-1013-9","volume":"110","author":"M Sone","year":"2005","unstructured":"Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol. 2005;110:19\u201326.","journal-title":"Acta Neuropathol"},{"key":"889_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-006-0160-y","volume":"113","author":"S Orimo","year":"2007","unstructured":"Orimo S, Kanazawa T, Nakamura A, Uchihara T, Mori F, Kakita A, et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol. 2007;113:81\u20136.","journal-title":"Acta Neuropathol"},{"key":"889_CR25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1440-1789.2007.00787.x","volume":"27","author":"Y Iwasaki","year":"2007","unstructured":"Iwasaki Y, Yoshida M, Hashizume Y, Hattori M, Aiba I, Sobue G. Widespread spinal cord involvement in progressive supranuclear palsy. Neuropathology. 2007;27:331\u201340.","journal-title":"Neuropathology"},{"key":"889_CR26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s004010051033","volume":"97","author":"H Kikuchi","year":"1999","unstructured":"Kikuchi H, Doh-ura K, Kira J, Iwaki T. Preferential neurodegeneration in the cervical spinal cord of progressive supranuclear palsy. Acta Neuropathol. 1999;97:577\u201384.","journal-title":"Acta Neuropathol"},{"key":"889_CR27","first-page":"171","volume":"18","author":"K Wakabayashi","year":"1999","unstructured":"Wakabayashi K, Hayashi S, Morita T, Shibasaki Y, Watanabe Y, Takahashi H. Neurofibrillary tangles in the peripheral sympathetic ganglia of non-Alzheimer elderly individuals. Clin Neuropathol. 1999;18:171\u20135.","journal-title":"Clin Neuropathol"},{"key":"889_CR28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","volume":"109","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol. 2005;109:583\u20138.","journal-title":"Acta Neuropathol"},{"key":"889_CR29","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/01.CIR.81.5.1606","volume":"81","author":"DS Goldstein","year":"1990","unstructured":"Goldstein DS, Chang PC, Eisenhofer G, Miletich R, Finn R, Bacher J, et al. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation. 1990;81:1606\u201321.","journal-title":"Circulation"},{"key":"889_CR30","doi-asserted-by":"crossref","unstructured":"Wong KK, Raffel DM, Bohnen NI, Altinok G, Gilman S, Frey KA. 2-Year natural decline of cardiac sympathetic innervation in idiopathic Parkinson disease studied with 11C-hydroxyephedrine (HED) PET. J Nucl Med. 2016.","DOI":"10.2967\/jnumed.116.176891"},{"key":"889_CR31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.arr.2016.01.001","volume":"30","author":"S Orimo","year":"2016","unstructured":"Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H. Brain imaging in Aging Special Issue of Ageing Research Reviews I\u2014meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in alpha-synucleinopathies. Ageing Res Rev. 2016;30:122\u201333.","journal-title":"Ageing Res Rev"},{"key":"889_CR32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.parkreldis.2013.11.001","volume":"20","author":"R Sakakibara","year":"2014","unstructured":"Sakakibara R, Tateno F, Kishi M, Tsuyusaki Y, Terada H, Inaoka T. MIBG myocardial scintigraphy in pre-motor Parkinson\u2019s disease: a review. Parkinsonism Relat Disord. 2014;20:267\u201373.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14802\/jmd.15015","volume":"8","author":"EJ Chung","year":"2015","unstructured":"Chung EJ, Kim SJ. (123)I-metaiodobenzylguanidine myocardial scintigraphy in lewy body-related disorders: a literature review. J Mov Disord. 2015;8:55\u201366. \n                      https:\/\/doi.org\/10.14802\/jmd.15015\n                      \n                    .","journal-title":"J Mov Disord"},{"key":"889_CR34","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1172\/JCI45803","volume":"121","author":"DS Goldstein","year":"2011","unstructured":"Goldstein DS, Holmes C, Kopin IJ, Sharabi Y. Intra-neuronal vesicular uptake of catecholamines is decreased in patients with Lewy body diseases. J Clin Invest. 2011;121:3320\u201330.","journal-title":"J Clin Invest"},{"key":"889_CR35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1999;67:189\u201394.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"889_CR36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00006231-199802000-00007","volume":"19","author":"M Yoshita","year":"1998","unstructured":"Yoshita M, Hayashi M, Hirai S. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson\u2019s disease. Nucl Med Commun. 1998;19:137\u201342.","journal-title":"Nucl Med Commun"},{"key":"889_CR37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/gps.4229","volume":"30","author":"S Slaets","year":"2015","unstructured":"Slaets S, Van Acker F, Versijpt J, Hauth L, Goeman J, Martin JJ, et al. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis. Int J Geriatr Psychiatry. 2015;30:864\u20139.","journal-title":"Int J Geriatr Psychiatry"},{"key":"889_CR38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.parkreldis.2011.02.001","volume":"17","author":"F Tateno","year":"2011","unstructured":"Tateno F, Sakakibara R, Kishi M, Ogawa E, Terada H, Ogata T, et al. Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic. Parkinsonism Relat Disord. 2011;17:395\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","volume":"76","author":"H Nagayama","year":"2005","unstructured":"Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2005;76:249\u201351.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"889_CR40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.parkreldis.2009.12.010","volume":"16","author":"K Kashihara","year":"2010","unstructured":"Kashihara K, Imamura T, Shinya T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson\u2019s disease. Parkinsonism Relat Disord. 2010;16:252\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR41","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","volume":"58","author":"DS Goldstein","year":"2002","unstructured":"Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST. Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease. Neurology. 2002;58:1247\u201355.","journal-title":"Neurology"},{"key":"889_CR42","first-page":"1099","volume":"47","author":"K Kashihara","year":"2006","unstructured":"Kashihara K, Ohno M, Kawada S, Okumura Y. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson\u2019s disease and dementia with Lewy bodies. J Nucl Med. 2006;47:1099\u2013101.","journal-title":"J Nucl Med"},{"key":"889_CR43","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.parkreldis.2015.07.009","volume":"21","author":"DS Goldstein","year":"2015","unstructured":"Goldstein DS, Holmes C, Sullivan P, Mash DC, Sidransky E, Stefani A, et al. Deficient vesicular storage: a common theme in catecholaminergic neurodegeneration. Parkinsonism Relat Disord. 2015;21:1013\u201322.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR44","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s13139-015-0354-0","volume":"49","author":"SH Kwon","year":"2015","unstructured":"Kwon SH, Yoon JK, Yoon JH, Lee SJ, Jo KS, Lee DH, et al. The utility of segmental analysis in cardiac I-123 MIBG SPECT in Parkinson\u2019s disease. Nucl Med Mol Imaging. 2015;49:298\u2013302.","journal-title":"Nucl Med Mol Imaging"},{"key":"889_CR45","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00702-015-1409-1","volume":"122","author":"JK Oh","year":"2015","unstructured":"Oh JK, Choi EK, Song IU, Kim JS, Chung YA. Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease. J Neural Transm (Vienna). 2015;122:1421\u20137.","journal-title":"J Neural Transm (Vienna)"},{"key":"889_CR46","doi-asserted-by":"crossref","first-page":"e0152746","DOI":"10.1371\/journal.pone.0152746","volume":"11","author":"H Odagiri","year":"2016","unstructured":"Odagiri H, Baba T, Nishio Y, Iizuka O, Matsuda M, Inoue K, et al. On the utility of MIBG SPECT\/CT in evaluating cardiac sympathetic dysfunction in Lewy body diseases. PLoS One. 2016;11:e0152746.","journal-title":"PLoS One"},{"key":"889_CR47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jns.2004.02.018","volume":"220","author":"S Saiki","year":"2004","unstructured":"Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M, et al. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci. 2004;220:105\u201311.","journal-title":"J Neurol Sci"},{"key":"889_CR48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.parkreldis.2010.08.011","volume":"16","author":"T Nomura","year":"2010","unstructured":"Nomura T, Inoue Y, Hogl B, Uemura Y, Kitayama M, Abe T, et al. Relationship between (123)I-MIBG scintigrams and REM sleep behavior disorder in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2010;16:683\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/ene.13206","volume":"24","author":"JS Kim","year":"2017","unstructured":"Kim JS, Park HE, Park IS, Oh YS, Ryu DW, Song IU, et al. Normal \u2018heart\u2019 in Parkinson\u2019s disease: is this a distinct clinical phenotype? Eur J Neurol. 2017;24:349\u201356.","journal-title":"Eur J Neurol"},{"key":"889_CR50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","volume":"12","author":"A Iranzo","year":"2013","unstructured":"Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. 2013;12:443\u201353.","journal-title":"Lancet Neurol"},{"key":"889_CR51","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/01.wnl.0000249313.25627.2e","volume":"67","author":"T Miyamoto","year":"2006","unstructured":"Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67:2236\u20138.","journal-title":"Neurology"},{"key":"889_CR52","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(18)30162-5","volume":"17","author":"K Knudsen","year":"2018","unstructured":"Knudsen K, Fedorova TD, Hansen AK, Sommerauer M, Otto M, Svendsen KB, et al. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. 2018;17:618\u201328. \n                      https:\/\/doi.org\/10.1016\/S1474-4422(18)30162-5\n                      \n                    .","journal-title":"Lancet Neurol"},{"key":"889_CR53","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1212\/WNL.53.5.1020","volume":"53","author":"S Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson\u2019s disease from multiple system atrophy. Neurology. 1999;53:1020\u20135.","journal-title":"Neurology"},{"key":"889_CR54","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s002590050548","volume":"27","author":"MJ Reinhardt","year":"2000","unstructured":"Reinhardt MJ, Jungling FD, Krause TM, Braune S. Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake. Eur J Nucl Med. 2000;27:595\u2013600.","journal-title":"Eur J Nucl Med"},{"key":"889_CR55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.parkreldis.2011.08.018","volume":"18","author":"K Berganzo","year":"2012","unstructured":"Berganzo K, Tijero B, Somme JH, Llorens V, Sanchez-Manso JC, Low D, et al. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy. Parkinsonism Relat Disord. 2012;18:45\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-510X(97)00278-5","volume":"155","author":"M Yoshita","year":"1998","unstructured":"Yoshita M. Differentiation of idiopathic Parkinson\u2019s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci. 1998;155:60\u20137.","journal-title":"J Neurol Sci"},{"key":"889_CR57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10286-011-0135-5","volume":"22","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cason E, Stefanelli A, Cocciolillo F, Di Giuda D, Fagioli G, et al. MIBG scintigraphy in differential diagnosis of parkinsonism: a meta-analysis. Clin Auton Res. 2012;22:43\u201355.","journal-title":"Clin Auton Res"},{"key":"889_CR58","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","volume":"18","author":"S Orimo","year":"2012","unstructured":"Orimo S, Suzuki M, Inaba A, Mizusawa H. 123I-MIBG myocardial scintigraphy for differentiating Parkinson\u2019s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2012;18:494\u2013500.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10286-013-0204-z","volume":"23","author":"W Jang","year":"2013","unstructured":"Jang W, Kim JS, Cho JW, Ahn JY, Choi YY, Kim HT. Thyroid MIBG uptake in Parkinson\u2019s disease with diabetes mellitus. Clin Auton Res. 2013;23:221\u20134.","journal-title":"Clin Auton Res"},{"key":"889_CR60","first-page":"224","volume":"40","author":"P Merlet","year":"1999","unstructured":"Merlet P, Pouillart F, Dubois-Rande JL, Delahaye N, Fumey R, Castaigne A, et al. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. J Nucl Med. 1999;40:224\u201331.","journal-title":"J Nucl Med"},{"key":"889_CR61","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s12350-015-0170-z","volume":"22","author":"AF Jacobson","year":"2015","unstructured":"Jacobson AF, Travin MI. Impact of medications on mIBG uptake, with specific attention to the heart: comprehensive review of the literature. J Nucl Cardiol. 2015;22:980\u201393.","journal-title":"J Nucl Cardiol"},{"key":"889_CR62","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"889_CR63","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1212\/WNL.42.11.2106","volume":"42","author":"WP Gai","year":"1992","unstructured":"Gai WP, Blumbergs PC, Geffen LB, Blessing WW. Age-related loss of dorsal vagal neurons in Parkinson\u2019s disease. Neurology. 1992;42:2106\u201311.","journal-title":"Neurology"},{"key":"889_CR64","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/brain\/86.4.781","volume":"86","author":"MJ Eadie","year":"1963","unstructured":"Eadie MJ. The pathology of certain medullary nuclei in parkinsonism. Brain. 1963;86:781\u201392.","journal-title":"Brain"},{"key":"889_CR65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett. 2006;396:67\u201372.","journal-title":"Neurosci Lett"},{"key":"889_CR66","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/ars.2014.5859","volume":"21","author":"JG Greene","year":"2014","unstructured":"Greene JG. Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson\u2019s disease. Antioxid Redox Signal. 2014;21:649\u201367.","journal-title":"Antioxid Redox Signal"},{"key":"889_CR67","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F. Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses. Acta Neuropathol. 1988;76:217\u201321.","journal-title":"Acta Neuropathol"},{"key":"889_CR68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012728","volume":"5","author":"T Lebouvier","year":"2010","unstructured":"Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N'Guyen JM, et al. Colonic biopsies to assess the neuropathology of Parkinson\u2019s disease and its relationship with symptoms. PLoS One. 2010;5:e12728.","journal-title":"PLoS One"},{"key":"889_CR69","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1111\/j.1365-2982.2012.01887.x","volume":"24","author":"H Pouclet","year":"2012","unstructured":"Pouclet H, Lebouvier T, Coron E, Des Varannes SB, Neunlist M, Derkinderen P. A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson\u2019s disease. Neurogastroenterol Motil. 2012;24:e202\u20135.","journal-title":"Neurogastroenterol Motil"},{"key":"889_CR70","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-012-1028-y","volume":"124","author":"K Tredici Del","year":"2012","unstructured":"Del Tredici K, Braak H. Spinal cord lesions in sporadic Parkinson\u2019s disease. Acta Neuropathol. 2012;124:643\u201364.","journal-title":"Acta Neuropathol"},{"key":"889_CR71","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White III CL, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010;119:689\u2013702.","journal-title":"Acta Neuropathol"},{"key":"889_CR72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0079-6123(08)61859-2","volume":"107","author":"DA Hopkins","year":"1996","unstructured":"Hopkins DA, Bieger D, de Vente J, Steinbusch WM. Vagal efferent projections: viscerotopy, neurochemistry and effects of vagotomy. Prog Brain Res. 1996;107:79\u201396.","journal-title":"Prog Brain Res"},{"key":"889_CR73","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H. Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33:599\u2013614.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"889_CR74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/mds.27138","volume":"33","author":"P Borghammer","year":"2018","unstructured":"Borghammer P. How does Parkinson\u2019s disease begin? Perspectives on neuroanatomical pathways, prions, and histology. Mov Disord. 2018;33:48\u201357.","journal-title":"Mov Disord"},{"key":"889_CR75","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol. 2015;78:522\u20139.","journal-title":"Ann Neurol"},{"key":"889_CR76","first-page":"154","volume":"31","author":"B Liu","year":"2016","unstructured":"Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, et al. Vagotomy and Parkinson\u2019s disease risk: a Swedish register-based matched cohort study. Mov Disord. 2016;31:154.","journal-title":"Mov Disord"},{"key":"889_CR77","first-page":"1714","volume":"7","author":"S Ito","year":"2014","unstructured":"Ito S, Takao M, Hatsuta H, Kanemaru K, Arai T, Saito Y, et al. Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease. Int J Clin Exp Pathol. 2014;7:1714\u201323.","journal-title":"Int J Clin Exp Pathol"},{"key":"889_CR78","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cne.10599","volume":"459","author":"M Anlauf","year":"2003","unstructured":"Anlauf M, Schafer MK, Eiden L, Weihe E. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes. J Comp Neurol. 2003;459:90\u2013111.","journal-title":"J Comp Neurol"},{"key":"889_CR79","volume-title":"Cholinesterases and cholinesterase inhibitors","author":"E Giacobini","year":"2000","unstructured":"Giacobini E. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd; 2000."},{"key":"889_CR80","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000145053","volume":"104","author":"W Schmid","year":"1979","unstructured":"Schmid W, van der Zypen E, Keller H. Die Wirkung einer subtotalen Vagotomie auf den Plexus myentericus (Auerbach) verschiedener Darmabschnitte. Acta Anat (Basel). 1979;104:36\u201351.","journal-title":"Acta Anat (Basel)"},{"key":"889_CR81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.autneu.2013.01.006","volume":"176","author":"DH Pauza","year":"2013","unstructured":"Pauza DH, Saburkina I, Rysevaite K, Inokaitis H, Jokubauskas M, Jalife J, et al. Neuroanatomy of the murine cardiac conduction system: a combined stereomicroscopic and fluorescence immunohistochemical study. Auton Neurosci. 2013;176:32\u201347.","journal-title":"Auton Neurosci"},{"key":"889_CR82","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2967\/jnumed.114.143859","volume":"55","author":"T Gjerloff","year":"2014","unstructured":"Gjerloff T, Jakobsen S, Nahimi A, Munk OL, Bender D, Alstrup AK, et al. In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses. J Nucl Med. 2014;55:1818\u201324.","journal-title":"J Nucl Med"},{"key":"889_CR83","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/awu369","volume":"138","author":"T Gjerloff","year":"2015","unstructured":"Gjerloff T, Fedorova T, Knudsen K, Munk OL, Nahimi A, Jacobsen S, et al. Imaging acetylcholinesterase density in peripheral organs in Parkinson\u2019s disease with 11C-donepezil PET. Brain. 2015;138:653\u201363.","journal-title":"Brain"},{"issue":"8","key":"889_CR84","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1212\/WNL.0000000000003633","volume":"88","author":"T Fedorova","year":"2017","unstructured":"Fedorova T, Seidelin LB, Knudsen K, Schacht AC, Geday J, Pavese N, et al. Decreased intestinal acetylcholinesterase in early Parkinson\u2019s disease: an 11C-donepezil PET study. Neurology. 2017;88(8):775\u201381.","journal-title":"Neurology"},{"key":"889_CR85","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(18)30162-5","volume":"17","author":"K Knudsen","year":"2018","unstructured":"\u2022\u2022 Knudsen K, Fedorova TD, Hansen AK, Sommerauer M, Otto M, Svendsen KB, et al. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. 2018;17:618\u201328 Comprehensive multi-modality imaging study which demonstrated fully developed pathology in the autonomic nervous system but relatively intact nigrostriatal dopaminergic innervation in patients with idiopathic RBD.","journal-title":"Lancet Neurol"},{"key":"889_CR86","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/cne.23198","volume":"521","author":"DF Sharrad","year":"2013","unstructured":"Sharrad DF, de Vries E, Brookes SJ. Selective expression of alpha-synuclein-immunoreactivity in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig rectum and human colon. J Comp Neurol. 2013;521:657\u201376.","journal-title":"J Comp Neurol"},{"key":"889_CR87","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cne.23296","volume":"521","author":"DF Sharrad","year":"2013","unstructured":"Sharrad DF, Gai WP, Brookes SJ. Selective coexpression of synaptic proteins, alpha-synuclein, cysteine string protein-alpha, synaptophysin, synaptotagmin-1, and synaptobrevin-2 in vesicular acetylcholine transporter-immunoreactive axons in the guinea pig ileum. J Comp Neurol. 2013;521:2523\u201337.","journal-title":"J Comp Neurol"},{"key":"889_CR88","doi-asserted-by":"publisher","unstructured":"\u2022 Tsukita K, Taguchi T, Sakamaki-Tsukita H, Tanaka K, Suenaga T. The vagus nerve becomes smaller in patients with Parkinson\u2019s disease: a preliminary cross-sectional study using ultrasonography. Parkinsonism Relat Disord. 2018. \n                      https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.002\n                      \n                     The first study to demonstrate reduced vagal nerve diameter in PD patients using ultrasonography.","DOI":"10.1016\/j.parkreldis.2018.06.002"},{"key":"889_CR89","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuroimage.2015.03.020","volume":"113","author":"NI Keren","year":"2015","unstructured":"Keren NI, Taheri S, Vazey EM, Morgan PS, Granholm AC, Aston-Jones GS, et al. Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. NeuroImage. 2015;113:235\u201345.","journal-title":"NeuroImage"},{"key":"889_CR90","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1212\/WNL.0000000000004496","volume":"89","author":"L Leclair-Visonneau","year":"2017","unstructured":"\u2022 Leclair-Visonneau L, Clairembault T, Coron E, Le Dily S, Vavasseur F, Dalichampt M, et al. REM sleep behavior disorder is related to enteric neuropathology in Parkinson disease. Neurology. 2017;89:1612\u20138 This study showed that RBD-positive PD patients exhibit significantly more pathological alpha-synuclein pathology in the intestine compared to RBD-negative cases.","journal-title":"Neurology"},{"key":"889_CR91","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/NEN.0b013e318258381b","volume":"71","author":"L Mu","year":"2012","unstructured":"Mu L, Sobotka S, Chen J, Su H, Sanders I, Adler CH, et al. Altered pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol. 2012;71:520\u201330.","journal-title":"J Neuropathol Exp Neurol"},{"key":"889_CR92","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1152\/ajplegacy.1907.19.3.436","volume":"19","author":"WB Cannon","year":"1907","unstructured":"Cannon WB. Oesophageal peristalsis after bilateral vagotomy. Am J Phys. 1907;19:436\u201344.","journal-title":"Am J Phys"},{"key":"889_CR93","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol. 2015;14:625\u201339.","journal-title":"Lancet Neurol"},{"key":"889_CR94","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/jnnp.2008.157701","volume":"80","author":"N Miller","year":"2009","unstructured":"Miller N, Allcock L, Hildreth AJ, Jones D, Noble E, Burn DJ. Swallowing problems in Parkinson disease: frequency and clinical correlates. J Neurol Neurosurg Psychiatry. 2009;80:1047\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"889_CR95","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.parkreldis.2011.11.006","volume":"18","author":"JG Kalf","year":"2012","unstructured":"Kalf JG, de Swart BJ, Bloem BR, Munneke M. Prevalence of oropharyngeal dysphagia in Parkinson\u2019s disease: a meta-analysis. Parkinsonism Relat Disord. 2012;18:311\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR96","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.apmr.2012.07.010","volume":"93","author":"CW Lin","year":"2012","unstructured":"Lin CW, Chang YC, Chen WS, Chang K, Chang HY, Wang TG. Prolonged swallowing time in dysphagic parkinsonism patients with aspiration pneumonia. Arch Phys Med Rehabil. 2012;93:2080\u20134.","journal-title":"Arch Phys Med Rehabil"},{"key":"889_CR97","unstructured":"Logemann J. Measurements of swallow from videofluoroscopic studies, 2 edn. Texas Pro-ed. 1993."},{"key":"889_CR98","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/PL00009512","volume":"12","author":"NA Leopold","year":"1997","unstructured":"Leopold NA, Kagel MC. Pharyngo-esophageal dysphagia in Parkinson\u2019s disease. Dysphagia. 1997;12:11\u20138 discussion 9-20.","journal-title":"Dysphagia"},{"key":"889_CR99","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1212\/WNL.39.10.1309","volume":"39","author":"M Bushmann","year":"1989","unstructured":"Bushmann M, Dobmeyer SM, Leeker L, Perlmutter JS. Swallowing abnormalities and their response to treatment in Parkinson\u2019s disease. Neurology. 1989;39:1309\u201314.","journal-title":"Neurology"},{"key":"889_CR100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0003489415617774","volume":"125","author":"JK Ellerston","year":"2016","unstructured":"Ellerston JK, Heller AC, Houtz DR, Kendall KA. Quantitative measures of swallowing deficits in patients with Parkinson\u2019s disease. Ann Otol Rhinol Laryngol. 2016;125:385\u201392.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"889_CR101","doi-asserted-by":"crossref","unstructured":"Suttrup I, Suttrup J, Suntrup-Krueger S, Siemer ML, Bauer J, Hamacher C, et al. Esophageal dysfunction in different stages of Parkinson\u2019s disease. Neurogastroenterol Motil. 2016:1\u20137.","DOI":"10.1111\/nmo.12915"},{"key":"889_CR102","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/mds.23290","volume":"25","author":"HY Sung","year":"2010","unstructured":"Sung HY, Kim JS, Lee KS, Kim YI, Song IU, Chung SW, et al. The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson\u2019s disease. Mov Disord. 2010;25:2361\u20138.","journal-title":"Mov Disord"},{"key":"889_CR103","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/mds.870120310","volume":"12","author":"BT Johnston","year":"1997","unstructured":"Johnston BT, Castell JA, Stumacher S, Colcher A, Gideon RM, Li Q, et al. Comparison of swallowing function in Parkinson\u2019s disease and progressive supranuclear palsy. Mov Disord. 1997;12:322\u20137.","journal-title":"Mov Disord"},{"key":"889_CR104","doi-asserted-by":"crossref","first-page":"e0197608","DOI":"10.1371\/journal.pone.0197608","volume":"13","author":"S Tomita","year":"2018","unstructured":"Tomita S, Oeda T, Umemura A, Kohsaka M, Park K, Yamamoto K, et al. Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson\u2019s disease. PLoS One. 2018;13:e0197608.","journal-title":"PLoS One"},{"key":"889_CR105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1353-8020(03)00045-2","volume":"9","author":"A Potulska","year":"2003","unstructured":"Potulska A, Friedman A, Krolicki L, Spychala A. Swallowing disorders in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2003;9:349\u201353.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR106","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.parkreldis.2015.09.043","volume":"21","author":"M Grunho","year":"2015","unstructured":"Grunho M, Sonies B, Frattali CM, Litvan I. Swallowing disturbances in the corticobasal syndrome. Parkinsonism Relat Disord. 2015;21:1342\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR107","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000487800","volume":"18","author":"HH Lee","year":"2018","unstructured":"Lee HH, Seo HG, Kim KD, Lee SH, Lee WH, Oh BM, et al. Characteristics of early oropharyngeal dysphagia in patients with multiple system atrophy. Neurodegener Dis. 2018;18:84\u201390.","journal-title":"Neurodegener Dis"},{"key":"889_CR108","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/WNL.48.6.1654","volume":"48","author":"I Litvan","year":"1997","unstructured":"Litvan I, Sastry N, Sonies BC. Characterizing swallowing abnormalities in progressive supranuclear palsy. Neurology. 1997;48:1654\u201362.","journal-title":"Neurology"},{"key":"889_CR109","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00455-015-9641-2","volume":"30","author":"H Taniguchi","year":"2015","unstructured":"Taniguchi H, Nakayama H, Hori K, Nishizawa M, Inoue M, Shimohata T. Esophageal involvement in multiple system atrophy. Dysphagia. 2015;30:669\u201373.","journal-title":"Dysphagia"},{"key":"889_CR110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/mds.25708","volume":"29","author":"S Marrinan","year":"2014","unstructured":"Marrinan S, Emmanuel AV, Burn DJ. Delayed gastric emptying in Parkinson\u2019s disease. Mov Disord. 2014;29:23\u201332.","journal-title":"Mov Disord"},{"key":"889_CR111","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.physiol.68.040504.094718","volume":"68","author":"KM Sanders","year":"2006","unstructured":"Sanders KM, Koh SD, Ward SM. Interstitial cells of cajal as pacemakers in the gastrointestinal tract. Annu Rev Physiol. 2006;68:307\u201343.","journal-title":"Annu Rev Physiol"},{"key":"889_CR112","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1212\/01.wnl.0000266593.50534.e8","volume":"69","author":"D Verbaan","year":"2007","unstructured":"Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ. Patient-reported autonomic symptoms in Parkinson disease. Neurology. 2007;69:333\u201341.","journal-title":"Neurology"},{"key":"889_CR113","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2967\/jnmt.109.067843","volume":"37","author":"KJ Donohoe","year":"2009","unstructured":"Donohoe KJ, Maurer AH, Ziessman HA, Urbain JL, Royal HD, Martin-Comin J, et al. Procedure guideline for adult solid-meal gastric-emptying study 3.0. J Nucl Med Technol. 2009;37:196\u2013200.","journal-title":"J Nucl Med Technol"},{"key":"889_CR114","doi-asserted-by":"publisher","unstructured":"Knudsen K, Szwebs M, Hansen AK, Borghammer P. Gastric emptying in Parkinson\u2019s disease\u2014a mini-review. Parkinsonism Relat Disord. 2018. \n                      https:\/\/doi.org\/10.1016\/j.parkreldis.2018.06.003\n                      \n                    .","DOI":"10.1016\/j.parkreldis.2018.06.003"},{"key":"889_CR115","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1212\/WNL.31.10.1288","volume":"31","author":"MA Evans","year":"1981","unstructured":"Evans MA, Broe GA, Triggs EJ, Cheung M, Creasey H, Paull PD. Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient. Neurology. 1981;31:1288\u201394.","journal-title":"Neurology"},{"key":"889_CR116","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.46.4.1051","volume":"46","author":"R Djaldetti","year":"1996","unstructured":"Djaldetti R, Baron J, Ziv I, Melamed E. Gastric emptying in Parkinson\u2019s disease: patients with and without response fluctuations. Neurology. 1996;46:1051\u20134.","journal-title":"Neurology"},{"key":"889_CR117","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/mds.1203","volume":"16","author":"R Hardoff","year":"2001","unstructured":"Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, et al. Gastric emptying time and gastric motility in patients with Parkinson\u2019s disease. Mov Disord. 2001;16:1041\u20137.","journal-title":"Mov Disord"},{"key":"889_CR118","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.parkreldis.2009.04.003","volume":"15","author":"A Krygowska-Wajs","year":"2009","unstructured":"Krygowska-Wajs A, Cheshire WP Jr, Wszolek ZK, Hubalewska-Dydejczyk A, Jasinska-Myga B, Farrer MJ, et al. Evaluation of gastric emptying in familial and sporadic Parkinson disease. Parkinsonism Relat Disord. 2009;15:692\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR119","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00415-010-5769-z","volume":"258","author":"Y Tanaka","year":"2011","unstructured":"Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, et al. Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson\u2019s disease? An analysis using the 13C-acetate breath test. J Neurol. 2011;258:421\u20136.","journal-title":"J Neurol"},{"key":"889_CR120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS One. 2011;6:e28032.","journal-title":"PLoS One"},{"key":"889_CR121","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/pgmj.72.845.164","volume":"72","author":"KN Davies","year":"1996","unstructured":"Davies KN, King D, Billington D, Barrett JA. Intestinal permeability and orocaecal transit time in elderly patients with Parkinson\u2019s disease. Postgrad Med J. 1996;72:164\u20137.","journal-title":"Postgrad Med J"},{"key":"889_CR122","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JPD-171131","volume":"7","author":"K Knudsen","year":"2017","unstructured":"Knudsen K, Haase AM, Fedorova TD, Bekker AC, Ostergaard K, Krogh K, et al. Gastrointestinal transit time in Parkinson\u2019s disease using a magnetic tracking system. J Parkinsons Dis. 2017;7:471\u20139.","journal-title":"J Parkinsons Dis"},{"key":"889_CR123","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mds.22841","volume":"25","author":"MM Unger","year":"2010","unstructured":"Unger MM, Hattemer K, Moller JC, Schmittinger K, Mankel K, Eggert K, et al. Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson\u2019s disease. Mov Disord. 2010;25:623\u20138.","journal-title":"Mov Disord"},{"key":"889_CR124","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00415-011-6372-7","volume":"259","author":"Y Tanaka","year":"2012","unstructured":"Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, et al. Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the (13)C-acetate breath test. J Neurol. 2012;259:1448\u201352.","journal-title":"J Neurol"},{"key":"889_CR125","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00415-005-0815-y","volume":"252","author":"T Thomaides","year":"2005","unstructured":"Thomaides T, Karapanayiotides T, Zoukos Y, Haeropoulos C, Kerezoudi E, Demacopoulos N, et al. Gastric emptying after semi-solid food in multiple system atrophy and Parkinson disease. J Neurol. 2005;252:1055\u20139.","journal-title":"J Neurol"},{"key":"889_CR126","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JPD-161050","volume":"7","author":"K Knudsen","year":"2017","unstructured":"\u2022 Knudsen K, Fedorova TD, Bekker AC, Iversen P, Ostergaard K, Krogh K, et al. Objective colonic dysfunction is far more prevalent than subjective constipation in Parkinson\u2019s disease: a colon transit and volume study. J Parkinsons Dis. 2017;7:359\u201367 This study demonstrated that objective, imaging-based markers of colonic dysfunction is considerably more prevalent than the subjective constipation symptoms experienced by the patients.","journal-title":"J Parkinsons Dis"},{"key":"889_CR127","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00702-015-1442-0","volume":"122","author":"J Dutkiewicz","year":"2015","unstructured":"Dutkiewicz J, Szlufik S, Nieciecki M, Charzynska I, Krolicki L, Smektala P, et al. Small intestine dysfunction in Parkinson\u2019s disease. J Neural Transm (Vienna). 2015;122:1659\u201361.","journal-title":"J Neural Transm (Vienna)"},{"key":"889_CR128","first-page":"118.e1","volume":"26","author":"Y Kimura","year":"2008","unstructured":"Kimura Y, Kamada Y, Kimura S. A patient with numerous tablets remaining in the stomach even 5 hours after ingestion. Am J Emerg Med. 2008;26:118.e1\u20132.","journal-title":"Am J Emerg Med"},{"key":"889_CR129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.parkreldis.2016.05.016","volume":"28","author":"E Svensson","year":"2016","unstructured":"Svensson E, Henderson VW, Borghammer P, Horvath-Puho E, Sorensen HT. Constipation and risk of Parkinson\u2019s disease: a Danish population-based cohort study. Parkinsonism Relat Disord. 2016;28:18\u201322.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR130","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1212\/WNL.0000000000004121","volume":"89","author":"A Iranzo","year":"2017","unstructured":"Iranzo A, Stefani A, Serradell M, Marti MJ, Lomena F, Mahlknecht P, et al. Characterization of patients with longstanding idiopathic REM sleep behavior disorder. Neurology. 2017;89:242\u20138.","journal-title":"Neurology"},{"key":"889_CR131","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.24921","volume":"27","author":"K Tredici Del","year":"2012","unstructured":"Del Tredici K, Braak H. Lewy pathology and neurodegeneration in premotor Parkinson\u2019s disease. Mov Disord. 2012;27:597\u2013607.","journal-title":"Mov Disord"},{"key":"889_CR132","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.parkreldis.2018.02.022","volume":"50","author":"A Schwiertz","year":"2018","unstructured":"\u2022 Schwiertz A, Spiegel J, Dillmann U, Grundmann D, Burmann J, Fassbender K, et al. Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2018;50:104\u20137 This recent study analyzed blood and stool samples and demonstrated increased intestinal inflammation and permeability in PD.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR133","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/ene.13398","volume":"24","author":"TH Mertsalmi","year":"2017","unstructured":"Mertsalmi TH, Aho VTE, Pereira PAB, Paulin L, Pekkonen E, Auvinen P, et al. More than constipation\u2014bowel symptoms in Parkinson\u2019s disease and their connection to gut microbiota. Eur J Neurol. 2017;24:1375\u201383.","journal-title":"Eur J Neurol"},{"key":"889_CR134","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mds.26866","volume":"32","author":"K Knudsen","year":"2017","unstructured":"Knudsen K, Krogh K, Ostergaard K, Borghammer P. Constipation in Parkinson\u2019s disease: subjective symptoms, objective markers, and new perspectives. Mov Disord. 2017;32:94\u2013105.","journal-title":"Mov Disord"},{"key":"889_CR135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/00365528809095938","volume":"152","author":"H Abrahamsson","year":"1988","unstructured":"Abrahamsson H, Antov S, Bosaeus I. Gastrointestinal and colonic segmental transit time evaluated by a single abdominal X-ray in healthy subjects and constipated patients. Scand J Gastroenterol Suppl. 1988;152:72\u201380.","journal-title":"Scand J Gastroenterol Suppl"},{"key":"889_CR136","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/mds.870080315","volume":"8","author":"WH Jost","year":"1993","unstructured":"Jost WH, Schimrigk K. Cisapride treatment of constipation in Parkinson\u2019s disease. Mov Disord. 1993;8:339\u201343.","journal-title":"Mov Disord"},{"key":"889_CR137","first-page":"535","volume":"110","author":"WH Jost","year":"1998","unstructured":"Jost WH, Schrank B. Defecatory disorders in de novo parkinsonians\u2014colonic transit and electromyogram of the external anal sphincter. Wien Klin Wochenschr. 1998;110:535\u20137.","journal-title":"Wien Klin Wochenschr"},{"key":"889_CR138","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.parkreldis.2011.06.002","volume":"17","author":"F Tateno","year":"2011","unstructured":"Tateno F, Sakakibara R, Yokoi Y, Kishi M, Ogawa E, Uchiyama T, et al. Levodopa ameliorated anorectal constipation in de novo Parkinson\u2019s disease: the QL-GAT study. Parkinsonism Relat Disord. 2011;17:662\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR139","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/mds.870120617","volume":"12","author":"W Ashraf","year":"1997","unstructured":"Ashraf W, Pfeiffer RF, Park F, Lof J, Quigley EM. Constipation in Parkinson\u2019s disease: objective assessment and response to psyllium. Mov Disord. 1997;12:946\u201351.","journal-title":"Mov Disord"},{"key":"889_CR140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2007-977489","volume":"20","author":"SR Steele","year":"2007","unstructured":"Steele SR, Mellgren A. Constipation and obstructed defecation. Clin Colon Rectal Surg. 2007;20:110\u20137.","journal-title":"Clin Colon Rectal Surg"},{"key":"889_CR141","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.parkreldis.2012.06.008","volume":"18","author":"A Damian","year":"2012","unstructured":"Damian A, Adler CH, Hentz JG, Shill HA, Caviness JN, Sabbagh MN, et al. Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;18:1089\u201393.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR142","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jnnp.74.2.268","volume":"74","author":"R Sakakibara","year":"2003","unstructured":"Sakakibara R, Odaka T, Uchiyama T, Asahina M, Yamaguchi K, Yamaguchi T, et al. Colonic transit time and rectoanal videomanometry in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2003;74:268\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"889_CR143","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/jnnp.51.12.1503","volume":"51","author":"SE Mathers","year":"1988","unstructured":"Mathers SE, Kempster PA, Swash M, Lees AJ. Constipation and paradoxical puborectalis contraction in anismus and Parkinson\u2019s disease: a dystonic phenomenon? J Neurol Neurosurg Psychiatry. 1988;51:1503\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"889_CR144","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT. Mov Disord. 2004;19:1306\u201312.","journal-title":"Mov Disord"},{"key":"889_CR145","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1111\/codi.12105","volume":"15","author":"CP Wang","year":"2013","unstructured":"Wang CP, Sung WH, Wang CC, Tsai PY. Early recognition of pelvic floor dyssynergia and colorectal assessment in Parkinson\u2019s disease associated with bowel dysfunction. Color Dis. 2013;15:e130\u20137.","journal-title":"Color Dis"},{"key":"889_CR146","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/nmo.12673","volume":"27","author":"M Nilsson","year":"2015","unstructured":"Nilsson M, Sandberg TH, Poulsen JL, Gram M, Frokjaer JB, Ostergaard LR, et al. Quantification and variability in colonic volume with a novel magnetic resonance imaging method. Neurogastroenterol Motil. 2015;27:1755\u201363.","journal-title":"Neurogastroenterol Motil"},{"key":"889_CR147","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/1531-8257(200001)15:1<71::AID-MDS1012>3.0.CO;2-W","volume":"15","author":"F Stocchi","year":"2000","unstructured":"Stocchi F, Badiali D, Vacca L, D'Alba L, Bracci F, Ruggieri S, et al. Anorectal function in multiple system atrophy and Parkinson\u2019s disease. Mov Disord. 2000;15:71\u20136.","journal-title":"Mov Disord"},{"key":"889_CR148","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.parkreldis.2016.12.007","volume":"35","author":"L Zhang","year":"2017","unstructured":"Zhang L, Cao B, Ou R, Wei QQ, Zhao B, Yang J, et al. Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes. Parkinsonism Relat Disord. 2017;35:63\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR149","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/mds.20165","volume":"19","author":"R Sakakibara","year":"2004","unstructured":"Sakakibara R, Odaka T, Uchiyama T, Liu R, Asahina M, Yamaguchi K, et al. Colonic transit time, sphincter EMG, and rectoanal videomanometry in multiple system atrophy. Mov Disord. 2004;19:924\u20139.","journal-title":"Mov Disord"},{"key":"889_CR150","first-page":"15","volume":"89","author":"LL Edwards","year":"1994","unstructured":"Edwards LL, Quigley EM, Harned RK, Hofman R, Pfeiffer RF. Characterization of swallowing and defecation in Parkinson\u2019s disease. Am J Gastroenterol. 1994;89:15\u201325.","journal-title":"Am J Gastroenterol"},{"key":"889_CR151","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2340\/16501977-0456","volume":"41","author":"CM Chiu","year":"2009","unstructured":"Chiu CM, Wang CP, Sung WH, Huang SF, Chiang SC, Tsai PY. Functional magnetic stimulation in constipation associated with Parkinson\u2019s disease. J Rehabil Med. 2009;41:1085\u20139.","journal-title":"J Rehabil Med"},{"key":"889_CR152","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1365-2036.2005.02669.x","volume":"22","author":"F Cadeddu","year":"2005","unstructured":"Cadeddu F, Bentivoglio AR, Brandara F, Marniga G, Brisinda G, Maria G. Outlet type constipation in Parkinson\u2019s disease: results of botulinum toxin treatment. Aliment Pharmacol Ther. 2005;22:997\u20131003.","journal-title":"Aliment Pharmacol Ther"},{"key":"889_CR153","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/1097-4598(200008)23:8<1250::AID-MUS14>3.0.CO;2-W","volume":"23","author":"R Libelius","year":"2000","unstructured":"Libelius R, Johansson F. Quantitative electromyography of the external anal sphincter in Parkinson\u2019s disease and multiple system atrophy. Muscle Nerve. 2000;23:1250\u20136.","journal-title":"Muscle Nerve"},{"key":"889_CR154","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/mds.1121","volume":"16","author":"DB Vodusek","year":"2001","unstructured":"Vodusek DB. Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord. 2001;16:600\u20137.","journal-title":"Mov Disord"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-018-0889-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0889-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-018-0889-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T23:23:08Z","timestamp":1568848988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-018-0889-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,19]]},"references-count":154,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1007\/s11910-018-0889-4","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,19]]},"assertion":[{"value":"19 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Borghammer has received consultancies from F. Hoffmann \u2013 La Roche and grant support from the Lundbeck and Jascha Foundations. Dr. Knudsen has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"79"}}